Current Drug Metabolism
Volume 20, 14 Issues, 2019
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
Ranking and Category
-
200th of 298 in
Biochemistry & Molecular Biology
-
158th of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Metabolism, Volume 14 - Number 2
Editorial
Antenatal Glucocorticoids Supplementation and Central Nervous System Development
, 14(2): 160 - 166Diego Gazzolo, Laura D. Serpero, Alessandro Frigiola, Raul Abella, Alessandro Giamberti, Giovanni Li Volti and Fabrizio Michetti
DOI: 10.2174/1389200211314020002
The Neonatal Kidney: Implications for Drug Metabolism and Elimination
, 14(2): 174 - 177I. Ligi, F. Boubred, I. Grandvuillemin and U. Simeoni
DOI: 10.2174/1389200211314020004
Paracetamol (Acetaminophen) Efficacy and Safety in the Newborn
, 14(2): 178 - 185Laura Cuzzolin, Roberto Antonucci and Vassilios Fanos
DOI: 10.2174/1389200211314020005
Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
, 14(2): 186 - 192Paolo Biban and Marcella Gaffuri
DOI: 10.2174/1389200211314020006
Triazole Use in the Nursery: Fluconazole, Voriconazole, Posaconazole, and Ravuconazole
, 14(2): 193 - 202Kevin Watt, Paolo Manzoni, Michael Cohen-Wolkowiez, Stefano Rizzollo, Elena Boano, Evelyne Jacqz-Aigrain and Daniel K. Benjamin
DOI: 10.2174/1389200211314020007
Echinocandins for the Nursery: An Update
, 14(2): 203 - 207Paolo Manzoni, Daniel K. Benjamin, Caterina Franco, Stefano Rizzollo, Mauro Stronati, Kevin Watt, Michael Cohen-Wolkowiez and Evelyne Jacqz-Aigrain
DOI: 10.2174/1389200211314020008
Pharmacokinetics, Pharmacodynamics and Clinical Use of Valganciclovir in Newborns with Symptomatic Congenital Cytomegalovirus Infection
, 14(2): 208 - 215Mauro Stronati, Giuseppina Lombardi, Francesca Garofoli, Paola Villani and Mario Regazzi
DOI: 10.2174/1389200211314020009
Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants
, 14(2): 216 - 225Marcello Lanari, Michela Silvestri and Giovanni A. Rossi
DOI: 10.2174/1389200211314020010
Effect of Alpha-1-Acid Glycoprotein Binding on Pharmacokinetics and Pharmacodynamics
, 14(2): 226 - 238Zeqi Huang and Thao Ung
DOI: 10.2174/1389200211314020011
Comparison of P450 Enzymes Between Cynomolgus Monkeys and Humans: P450 Identities, Protein Contents, Kinetic Parameters, and Potential for Inhibitory Profiles
, 14(2): 239 - 252Chie Emoto, Noriaki Yoda, Yasuhiro Uno, Kazuhide Iwasaki, Ken Umehara, Eiji Kashiyama and Hiroshi Yamazaki
DOI: 10.2174/1389200211314020012
An overview of ABC and SLC Drug Transporter Gene Regulation
, 14(2): 253 - 264Qiu-Xia Chen, Hai-Hong Hu, Quan Zhou, Ai-Ming Yu and Su Zeng
DOI: 10.2174/1389200211314020013
Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension
, 14(2): 265 - 269Serap Gur, Philip J. Kadowitz, Ahmet Gokce, Suresh C. Sikka, Utku Lokman and Wayne J.G. Hellstrom
DOI: 10.2174/1389200211314020014
  |
Editor-in-Chief
Michael Sinz
Bristol Myers Squibb
Princeton, NJ
USA
Biography
View Full Editorial Board
Bristol Myers Squibb
Princeton, NJ
USA
Biography
Biography of Michael Sinz
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Metabolism was launched in 2000. Dr. Michael Sinz serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net